Paper36901797
Aducanumab-Hope or Disappointment for Alzheimer's Disease.
Wojtunik-Kulesza K and 2 others. Int J Mol Sci, 2023. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Aducanumab-Hope or Disappointment for Alzheimer's Disease. Papers, record 36901797. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901797
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Humans | |
| Amyloid beta-Peptides | |
| Antibodies, Monoclonal, Humanized | |
| Emotions | |
| Immunoglobulin G |
Source PubMed
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27582220 | The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. | Nature | 2016 | https://conductscience.org/library/papers/27582220 | PubMed |
| 2 | 36142659 | Regulation of the Soluble Amyloid Precursor Protein α (sAPPα) Levels by Acetylcholinesterase and Brain-Derived Neurotrophic Factor in Lung Cancer Cell Media. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142659 | PubMed |
| 3 | 8894693 | cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. | Hum Mol Genet | 1996 | https://conductscience.org/library/papers/8894693 | PubMed |
| 4 | 30011822 | Precision Medicine for Alzheimer's Disease Prevention. | Healthcare (Basel) | 2018 | https://conductscience.org/library/papers/30011822 | PubMed |
| 5 | 27048170 | Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody. | Alzheimers Res Ther | 2016 | https://conductscience.org/library/papers/27048170 | PubMed |
| 6 | 32941929 | Alzheimer's disease: Recent treatment strategies. | Eur J Pharmacol | 2020 | https://conductscience.org/library/papers/32941929 | PubMed |
| 7 | 22920732 | Monoclonal antibody therapeutics: history and future. | Curr Opin Pharmacol | 2012 | https://conductscience.org/library/papers/22920732 | PubMed |
| 8 | 30938796 | Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia. | JAMA | 2019 | https://conductscience.org/library/papers/30938796 | PubMed |
| 9 | 27810931 | Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice. | J Neurosci | 2016 | https://conductscience.org/library/papers/27810931 | PubMed |
| 10 | 33319314 | A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease. | Acta Neuropathol | 2021 | https://conductscience.org/library/papers/33319314 | PubMed |
| 11 | 28691573 | Plasticity in the Working Memory System: Life Span Changes and Response to Injury. | Neuroscientist | 2018 | https://conductscience.org/library/papers/28691573 | PubMed |
| 12 | 20813343 | Alzheimer's disease, a multifactorial disorder seeking multitherapies. | Alzheimers Dement | 2010 | https://conductscience.org/library/papers/20813343 | PubMed |
| 13 | 30787102 | In vivo localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease. | J Biol Chem | 2019 | https://conductscience.org/library/papers/30787102 | PubMed |
| 14 | 21257651 | Brain microbleeds and Alzheimer's disease: innocent observation or key player? | Brain | 2011 | https://conductscience.org/library/papers/21257651 | PubMed |
| 15 | 18056160 | Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology. | Brain | 2008 | https://conductscience.org/library/papers/18056160 | PubMed |
| 16 | 1172191 | Continuous cultures of fused cells secreting antibody of predefined specificity. | Nature | 1975 | https://conductscience.org/library/papers/1172191 | PubMed |
| 17 | 23703910 | Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23703910 | PubMed |
| 18 | 22487856 | Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. | J Neuropathol Exp Neurol | 2012 | https://conductscience.org/library/papers/22487856 | PubMed |
| 19 | 29686315 | Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β. | Sci Rep | 2018 | https://conductscience.org/library/papers/29686315 | PubMed |
| 20 | 34595939 | Accelerated Approval of Aducanumab: Where Do We Stand Now? | Ann Pharmacother | 2022 | https://conductscience.org/library/papers/34595939 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42389265 | Advances in the treatment of Alzheimer's disease. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42389265 | PubMed |
| 42286894 | A mechanistic framework linking the oral microbiome to Alzheimer's disease through neuroinflammation. | J Alzheimers Dis | 2026 | https://conductscience.org/library/papers/42286894 | PubMed |
| 42277828 | Meningeal lymphatic dysfunction in Alzheimer's disease: molecular mechanisms, clinical implications, and future perspectives. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42277828 | PubMed |
| 42229063 | Friend or foe? Glial-vascular interactions in health and neurodegenerative disease. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/42229063 | PubMed |
| 42038337 | Cynanchum bungei Decne-derived extracellular vesicles alleviate cognitive impairment and pathological damage in Alzheimer's disease. | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/42038337 | PubMed |
| 42038088 | Depression as an early symptom and risk factor of dementia - a narrative review. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42038088 | PubMed |
| 41870777 | Bridging the gaps in alzheimer's disease: a comprehensive review of current and emerging therapies. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41870777 | PubMed |
| 41760646 | Synthesis of 3-desoxycollinoketone B and its ability to reduce Alzheimer-associated misfolded proteins. | Nat Commun | 2026 | https://conductscience.org/library/papers/41760646 | PubMed |
| 40914973 | Integrative physiology of skeletal muscle for maintaining cognitive health. | J Physiol | 2026 | https://conductscience.org/library/papers/40914973 | PubMed |
| 40806679 | The Therapeutic Potential of Glymphatic System Activity to Reduce the Pathogenic Accumulation of Cytotoxic Proteins in Alzheimer's Disease. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806679 | PubMed |
| 40546798 | Potential Applications of Natural Components of Traditional Chinese Medicine Delivery via Nanoparticle Drug Delivery Systems in the Treatment of Alzheimer's Disease. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40546798 | PubMed |
| 40507988 | The Role of Inflammation in Neurodegenerative Diseases: Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40507988 | PubMed |
| 40503182 | Tracing the aggregation pathway of the scaffold protein DISC1: Structural implications for chronic mental illnesses. | J Struct Biol X | 2025 | https://conductscience.org/library/papers/40503182 | PubMed |
| 40429735 | N-N-Substituted Piperazine, Cmp2, Improves Cognitive and Motor Functions in 5xFAD Mice. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40429735 | PubMed |
| 40095208 | Intranasal Delivery of Lithium Salt Suppresses Inflammatory Pyroptosis in the Brain and Ameliorates Memory Loss and Depression-like Behavior in 5XFAD Mice. | J Neuroimmune Pharmacol | 2025 | https://conductscience.org/library/papers/40095208 | PubMed |
| 40002308 | Inflammasomes in Alzheimer's Progression: Nrf2 as a Preventive Target. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40002308 | PubMed |
| 39962970 | Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's disease. | J Alzheimers Dis | 2025 | https://conductscience.org/library/papers/39962970 | PubMed |
| 39926227 | Nanoscale drug formulations for the treatment of Alzheimer's disease progression. | RSC Adv | 2025 | https://conductscience.org/library/papers/39926227 | PubMed |
| 39806952 | Design, Synthesis, Biological Evaluation and Docking Studies of 2-hydroxy-4-benzyloxy Chalcone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease. | Curr Med Chem | 2026 | https://conductscience.org/library/papers/39806952 | PubMed |
| 39559726 | Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals. | Beilstein J Nanotechnol | 2024 | https://conductscience.org/library/papers/39559726 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36901797
GET https://conductscience.org/api/papers/v1/36901797/references?page=2